LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
35 hedge funds and large institutions have $331M invested in Landos Biopharma, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 15 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
33% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 15
Holders
35
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.39M | |
| 2 | +$275K | |
| 3 | +$265K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$222K |
| 5 |
Renaissance Technologies
New York
|
+$159K |
Top Sellers
| 1 | -$5.81M | |
| 2 | -$947K | |
| 3 | -$882K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$398K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$213K |